To ask the Secretary of State for Business, Energy and Industrial Strategy, pursuant to the Answer of 11 January to Question 130668, if he will name the projects that received funding in 2019-20 from the (a) Medical Research Council and (b) National Institute for Health Research.
Answered on
14 January 2021
The Medical Research Council (MRC) funded seven Motor Neurone Disease-related projects in 2019-20 in pursuant to the Answer of 11 January to Question 130668. Details of the projects can be found in the table below.
Research Organisation | Project Title | Start Date | End Date | Amount Awarded (£m) |
University College London | The impact of TDP-43 on translation and the response to axonal damage in amyotrophic lateral sclerosis | 01/10/2019 | 30/09/2024 | £1.9m |
University College London | Elucidating early stage ALS pathomecanisms that drive mitochondrial dysfunction | 01/01/2020 | 31/12/2022 | £0.9m |
University of Sheffield | Regulation of ER-mitochondria contacts in neurodegeneration | 01/07/2019 | 30/09/2022 | £0.6m |
University College London | A 5 year prospective follow-up clinical and imaging investigation of demyelinating clinically isolated syndrome (CIS) | 01/09/2019 | 31/08/2023 | £0.8m |
Imperial College London | Regulated proteolysis of p62/SQSTM1, nutrient-sensing and human disease | 01/02/2020 | 31/01/2023 | £0.5m |
University of Edinburgh | Investigating the molecular mechanisms of mutant C9orf72 human iPSC-derived astrocyte-mediated motor neuron deficits | 01/08/2019 | 31/01/2022 | £0.2m |
Newcastle University | Novel MRI Biomarkers in Neuromuscular Disease | 01/09/2019 | 31/08/2022 | £0.1m |
The National Institute for Health Research (NIHR) funded no Motor Neurone Disease-related projects during this period.
Further details of all projects funded by UK Research and Innovation (UKRI), which MRC has been integrated into, can be found at https://gtr.ukri.org/.